KEGG   COMPOUND: C00041
Entry
C00041                      Compound                               
Name
L-Alanine;
L-2-Aminopropionic acid;
L-alpha-Alanine
Formula
C3H7NO2
Exact mass
89.0477
Mol weight
89.09
Structure
Remark
Same as: D00012
Reaction
R00258 R00369 R00396 R00397 R00398 R00400 R00401 R00453
R00576 R00585 R00692 R00863 R00907 R00987 R01215 R01261
R01712 R02050 R02271 R02293 R02668 R02970 R03001 R03038
R03193 R03210 R03502 R03599 R03854 R03936 R04112 R04152
R04187 R05652 R07460 R08197 R08714 R08872 R09048 R09254
R10124 R10178 R10180 R10992 R11038 R11064 R11528 R11583
R12343 R12417 R12419 R12622 R12725 R12727 R13583
Pathway
map00250  Alanine, aspartate and glutamate metabolism
map00270  Cysteine and methionine metabolism
map00430  Taurine and hypotaurine metabolism
map00450  Selenocompound metabolism
map00470  D-Amino acid metabolism
map00710  Carbon fixation by Calvin cycle
map00970  Aminoacyl-tRNA biosynthesis
map00997  Biosynthesis of various other secondary metabolites
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01200  Carbon metabolism
map01210  2-Oxocarboxylic acid metabolism
map01230  Biosynthesis of amino acids
map01502  Vancomycin resistance
map02010  ABC transporters
map04122  Sulfur relay system
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05230  Central carbon metabolism in cancer
Module
M00171  C4-dicarboxylic acid cycle, NAD - malic enzyme type
M00901  Fumiquinazoline biosynthesis, tryptophan + alanine + anthranilate => fumiquinazoline
Enzyme
1.4.1.1         1.5.1.17        2.3.1.47        2.6.1.2         
2.6.1.12        2.6.1.15        2.6.1.18        2.6.1.30        
2.6.1.37        2.6.1.40        2.6.1.41        2.6.1.43        
2.6.1.44        2.6.1.46        2.6.1.47        2.6.1.51        
2.6.1.56        2.6.1.58        2.6.1.66        2.6.1.71        
2.6.1.77        2.6.1.84        2.6.1.96        2.6.1.99        
2.6.1.108       2.6.1.113       2.6.1.115       2.6.1.119       
2.6.1.-         2.8.1.7         2.8.1.9         3.5.1.28        
3.7.1.3         4.1.1.12        4.1.1.64        4.4.1.16        
5.1.1.1         6.1.1.7         6.2.1.67        6.3.2.8         
6.3.2.49        6.3.2.-
 » show all
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00041  Alanine (Ala)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Alanine
    D00012  Alanine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00012  L-Alanine
Other DBs
CAS: 56-41-7
PubChem: 3343
KNApSAcK: C00001332
PDB-CCD: ALA[PDBj]
NIKKAJI: J9.168E
LinkDB
KCF data

ATOM        6
            1   O6a O    22.7503  -15.7507
            2   C6a C    23.9627  -15.0506
            3   C1c C    25.1753  -15.7507
            4   C1a C    26.3878  -15.0506
            5   O6a O    23.9627  -13.6508
            6   N1a N    25.1753  -17.1506
BOND        5
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     2   5 2
            5     3   6 1 #Down

» Japanese version

KEGG   COMPOUND: C00065
Entry
C00065                      Compound                               
Name
L-Serine;
L-2-Amino-3-hydroxypropionic acid;
L-3-Hydroxy-alanine;
Serine
Formula
C3H7NO3
Exact mass
105.0426
Mol weight
105.09
Structure
Remark
Same as: D00016
Reaction
R00220 R00581 R00582 R00584 R00585 R00586 R00588 R00589
R00590 R00674 R00891 R00945 R01281 R01289 R01290 R01800
R02378 R02563 R02722 R02817 R03662 R03923 R04942 R06126
R07376 R07377 R07644 R08218 R09099 R10255 R10441 R10880
R10984 R10985 R10986 R11667 R12342 R12344 R12757 R12779
R12781 R13249 R13576
Pathway
map00260  Glycine, serine and threonine metabolism
map00261  Monobactam biosynthesis
map00270  Cysteine and methionine metabolism
map00460  Cyanoamino acid metabolism
map00470  D-Amino acid metabolism
map00564  Glycerophospholipid metabolism
map00600  Sphingolipid metabolism
map00630  Glyoxylate and dicarboxylate metabolism
map00670  One carbon pool by folate
map00680  Methane metabolism
map00920  Sulfur metabolism
map00970  Aminoacyl-tRNA biosynthesis
map00997  Biosynthesis of various other secondary metabolites
map00998  Biosynthesis of various antibiotics
map01054  Nonribosomal peptide structures
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01200  Carbon metabolism
map01230  Biosynthesis of amino acids
map01240  Biosynthesis of cofactors
map01502  Vancomycin resistance
map02010  ABC transporters
map04071  Sphingolipid signaling pathway
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05230  Central carbon metabolism in cancer
Module
M00020  Serine biosynthesis, glycerate-3P => serine
M00021  Cysteine biosynthesis, serine => cysteine
M00035  Methionine degradation
M00094  Ceramide biosynthesis
M00338  Cysteine biosynthesis, homocysteine + serine => cysteine
M00346  Formaldehyde assimilation, serine pathway
M00532  Photorespiration
M00736  Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A
M00785  Cycloserine biosynthesis, arginine/serine => cycloserine
M00875  Staphyloferrin B biosynthesis, L-serine => staphyloferrin B
M00975  Betaine degradation, bacteria, betaine => pyruvate
Network
nt06030  Methionine metabolism
nt06033  Glycine, serine and arginine metabolism
nt06038  Folate metabolism
nt06545  Cornified envelope formation
Enzyme
1.1.1.276       1.1.1.387       1.4.1.7         2.1.2.1         
2.3.1.30        2.3.1.50        2.6.1.45        2.6.1.51        
2.7.1.80        2.7.1.225       2.7.1.226       2.7.8.4         
2.7.8.8         2.7.8.29        2.7.8.38        2.8.1.4         
3.1.3.3         3.1.4.13        4.1.1.-         4.2.1.20        
4.2.1.22        4.2.1.50        4.2.1.122       4.3.1.17        
4.3.1.19        5.1.1.10        5.1.1.18        6.1.1.11        
6.2.1.72        6.3.2.14        6.3.2.-
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00065  Serine (Ser)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00016  L-Serine
Other DBs
CAS: 56-45-1
PubChem: 3365
KNApSAcK: C00001393
PDB-CCD: SER[PDBj]
NIKKAJI: J1.195I
LinkDB
KCF data

ATOM        7
            1   C1c C    23.5961  -17.5357
            2   C6a C    22.4445  -16.7873
            3   C1b C    24.8238  -16.8518
            4   N1a N    23.6370  -18.9388
            5   O6a O    21.2226  -17.4714
            6   O6a O    22.4677  -15.3785
            7   O1a O    26.0339  -17.5708
BOND        6
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 2
            6     3   7 1

» Japanese version

KEGG   COMPOUND: C00097
Entry
C00097                      Compound                               
Name
L-Cysteine;
L-2-Amino-3-mercaptopropionic acid
Formula
C3H7NO2S
Exact mass
121.0198
Mol weight
121.16
Structure
Remark
Same as: D00026
Reaction
R00782 R00891 R00892 R00893 R00894 R00895 R00896 R00897
R00899 R00900 R00901 R00903 R01001 R01113 R02409 R02508
R02743 R03217 R03260 R03524 R03650 R03923 R04230 R04231
R04859 R04870 R07274 R07360 R07460 R08168 R08608 R08632
R08653 R08659 R08666 R08685 R08848 R09562 R09591 R10409
R10670 R10672 R10736 R11014 R11015 R11524 R11528 R11583
R12765 R12767 R13363 R13404 R13405
Pathway
map00260  Glycine, serine and threonine metabolism
map00270  Cysteine and methionine metabolism
map00311  Penicillin and cephalosporin biosynthesis
map00430  Taurine and hypotaurine metabolism
map00460  Cyanoamino acid metabolism
map00470  D-Amino acid metabolism
map00480  Glutathione metabolism
map00670  One carbon pool by folate
map00730  Thiamine metabolism
map00770  Pantothenate and CoA biosynthesis
map00920  Sulfur metabolism
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01200  Carbon metabolism
map01230  Biosynthesis of amino acids
map01240  Biosynthesis of cofactors
map01320  Sulfur cycle
map04122  Sulfur relay system
map04216  Ferroptosis
map04974  Protein digestion and absorption
map05230  Central carbon metabolism in cancer
Module
M00021  Cysteine biosynthesis, serine => cysteine
M00338  Cysteine biosynthesis, homocysteine + serine => cysteine
M00609  Cysteine biosynthesis, methionine => cysteine
M00672  Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin
M00673  Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C
Network
nt06026  Glutathione biosynthesis
nt06030  Methionine metabolism
nt06525  Ferroptosis
Enzyme
1.8.1.6         1.8.1.9         1.8.1.10        1.8.3.5         
1.8.3.6         1.8.4.3         1.8.4.4         1.13.11.20      
1.13.11.95      1.14.14.43      1.14.14.45      1.14.99.52      
1.14.-.-        1.21.3.10       2.5.1.47        2.5.1.48        
2.5.1.49        2.5.1.65        2.5.1.160       2.6.1.1         
2.6.1.3         2.8.1.4         2.8.1.7         2.8.1.9         
3.4.11.1        3.4.11.2        3.4.11.23       3.4.13.-        
3.13.1.6        4.2.1.22        4.3.2.9         4.4.1.1         
4.4.1.9         4.4.1.10        4.4.1.13        4.4.1.28        
5.1.1.10        6.1.1.16        6.2.1.69        6.3.1.13        
6.3.2.2         6.3.2.5         6.3.2.26        6.3.2.51
 » show all
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00097  Cysteine (Cys)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D00026  L-Cysteine (JP18)
Classification of Japanese OTC drugs [BR:br08313]
 Nourishing tonics and health supplements
  45 Protein and amino acid based drugs
   D00026  L-Cysteine (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Cysteine
    D00026  L-Cysteine (JP18)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00026  L-Cysteine
Other DBs
CAS: 52-90-4
PubChem: 3397
KNApSAcK: C00001351
PDB-CCD: CYS[PDBj]
NIKKAJI: J9.167G
LinkDB
KCF data

ATOM        7
            1   C1c C    24.5141  -15.4370
            2   C6a C    23.3459  -14.6895
            3   C1b C    25.7289  -14.7361
            4   N1a N    24.5609  -16.8388
            5   O6a O    22.1311  -15.3436
            6   O6a O    23.3459  -13.2877
            7   S1a S    26.9438  -15.4838
BOND        6
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 2
            6     3   7 1

» Japanese version

KEGG   COMPOUND: C00188
Entry
C00188                      Compound                               
Name
L-Threonine;
2-Amino-3-hydroxybutyric acid
Formula
C4H9NO3
Exact mass
119.0582
Mol weight
119.12
Structure
Remark
Same as: D00041
Reaction
R00751 R00996 R01465 R01466 R01467 R03663 R06531 R07247
R08323 R10463 R10888 R10891 R10892 R12772 R12774
Pathway
map00260  Glycine, serine and threonine metabolism
map00261  Monobactam biosynthesis
map00290  Valine, leucine and isoleucine biosynthesis
map00470  D-Amino acid metabolism
map00860  Porphyrin metabolism
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01230  Biosynthesis of amino acids
map02010  ABC transporters
map04974  Protein digestion and absorption
map04978  Mineral absorption
Module
M00018  Threonine biosynthesis, aspartate => homoserine => threonine
M00570  Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine
Enzyme
1.1.1.103       2.2.1.8         2.7.1.177       2.7.7.87        
3.4.-.-         4.1.2.5         4.1.2.48        4.2.3.1         
4.3.1.19        5.1.1.6         6.1.1.3         6.2.1.70        
6.3.2.-
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00188  Threonine (Thr)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Threonine
    D00041  Threonine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00041  L-Threonine
Other DBs
CAS: 72-19-5
PubChem: 3488
KNApSAcK: C00001394
PDB-CCD: THR[PDBj]
NIKKAJI: J21.883I
LinkDB
KCF data

ATOM        8
            1   O6a O    22.5407  -18.2704
            2   C6a C    23.7531  -17.5704
            3   C1c C    24.9657  -18.2704
            4   C1c C    26.1781  -17.5704
            5   C1a C    27.3906  -18.2704
            6   O6a O    23.7531  -16.1705
            7   N1a N    24.9657  -19.6703
            8   O1a O    26.1781  -16.1703
BOND        7
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     2   6 2
            6     3   7 1 #Down
            7     4   8 1 #Down

» Japanese version

KEGG   COMPOUND: C00064
Entry
C00064                      Compound                               
Name
L-Glutamine;
L-2-Aminoglutaramic acid
Formula
C5H10N2O3
Exact mass
146.0691
Mol weight
146.14
Structure
Remark
Same as: D00015
Reaction
R00021 R00093 R00114 R00253 R00256 R00257 R00573 R00575
R00576 R00577 R00578 R00579 R00768 R00986 R01072 R01149
R01231 R01375 R01716 R02576 R02781 R02895 R03652 R03905
R04011 R04212 R04463 R04558 R05224 R05225 R05815 R07456
R08244 R08855 R08890 R08891 R08956 R09195 R09598 R09599
R10089 R11515 R11627 R11941 R12352 R12478 R12507 R12590
R12939 R13353 R13355
Pathway
map00220  Arginine biosynthesis
map00230  Purine metabolism
map00240  Pyrimidine metabolism
map00250  Alanine, aspartate and glutamate metabolism
map00470  D-Amino acid metabolism
map00630  Glyoxylate and dicarboxylate metabolism
map00750  Vitamin B6 metabolism
map00910  Nitrogen metabolism
map00970  Aminoacyl-tRNA biosynthesis
map01060  Biosynthesis of plant secondary metabolites
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map01120  Microbial metabolism in diverse environments
map01230  Biosynthesis of amino acids
map01232  Nucleotide metabolism
map01240  Biosynthesis of cofactors
map02010  ABC transporters
map02020  Two-component system
map04382  Cornified envelope formation
map04724  Glutamatergic synapse
map04727  GABAergic synapse
map04964  Proximal tubule bicarbonate reclamation
map04974  Protein digestion and absorption
map04978  Mineral absorption
map05230  Central carbon metabolism in cancer
Module
M00048  De novo purine biosynthesis, PRPP + glutamine => IMP
M00051  De novo pyrimidine biosynthesis, glutamine (+ PRPP) => UMP
M00916  Pyridoxal phosphate biosynthesis, R5P + glyceraldehyde-3P + glutamine => pyridoxal-P
M00978  Ornithine-ammonia cycle
Network
nt06544  Neuroactive ligand signaling
Enzyme
1.4.1.13        1.4.1.14        1.4.7.1         2.3.1.14        
2.3.1.68        2.3.2.1         2.3.2.14        2.4.2.14        
2.6.1.15        2.6.1.16        2.6.1.50        2.6.1.64        
2.6.1.85        2.6.1.86        2.6.1.100       2.6.1.101       
2.6.1.117       2.6.1.123       2.7.3.13        3.5.1.2         
3.5.1.38        3.5.1.133       4.1.3.27        4.3.2.10        
4.3.3.6         4.3.3.9         5.1.1.10        6.1.1.18        
6.3.1.2         6.3.4.2         6.3.5.1         6.3.5.2         
6.3.5.3         6.3.5.4         6.3.5.5         6.3.5.6         
6.3.5.7         6.3.5.9         6.3.5.10        6.3.5.11        
6.3.5.12        6.3.5.13        6.3.5.-
 » show all
Brite
Compounds with biological roles [BR:br08001]
 Peptides
  Amino acids
   Common amino acids
    C00064  Glutamine (Gln)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
    A16AA Amino acids and derivatives
     A16AA03 Glutamine
      D00015  Glutamine (USP) <US>
USP drug classification [BR:br08302]
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
  Glutamine
   D00015  Glutamine (USP)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   L-Glutamine
    D00015  Glutamine (USP)
Drug groups [BR:br08330]
 Gastrointestinal agent
  DG01975  Agents for peptic ulcer
   DG02008  Gastric mucosal protectant
    D00015  Glutamine
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00015  L-Glutamine
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D00015
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D00015
Other DBs
CAS: 56-85-9
PubChem: 3364
KNApSAcK: C00001359
PDB-CCD: GLN[PDBj]
NIKKAJI: J9.170G
LinkDB
KCF data

ATOM        10
            1   C1c C    23.8378  -17.4606
            2   C1b C    25.0254  -16.7178
            3   C6a C    22.6035  -16.7995
            4   N1a N    23.8787  -18.8587
            5   C1b C    26.2597  -17.3787
            6   O6a O    21.4451  -17.5952
            7   O6a O    22.6209  -15.4015
            8   C5a C    27.4472  -16.6416
            9   N1a N    28.6814  -17.3027
            10  O5a O    27.4704  -15.2435
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     8   9 1
            9     8  10 2

» Japanese version

DBGET integrated database retrieval system